PeckiiLess – Nano sensor research for blood glucose monitoring through human exhalation
PeckiiLess will not only remove the invasiveness, waste and high cost of current methods, we will offer an accurate monitoring product for the roughly 40% of people who need to check their glucose but do not have access to the technology due to their limitations. The purpose of the application to the Sten K foundation is to obtain funds for PeckiiLess to further the research on the nanosensor with experts at Lund University. We have worked with Nano Lund in the past and seek to further this work
Development of a new cancer therapy aimed at one of the most common genetic defects in cancer cells
Most SCLC patients survive one year or less after diagnosis. Our aim is to develop a drug against SCLC, which is both more effective than the current treatment recommendations and which also leads to fewer side effects. The hypothesis that we want to evaluate is whether treatment with L12 shows a better effect than the therapies that are available today, as well as evaluate basic pharmacokinetic properties of the molecule.
A novel non-invasive imaging tool for the early screening for Alzheimer’s disease.
Mantis photonics AB
Our solution is perfectly suited for the screening of the population above 50 years. As 40 percent of dementia are preventable by lifestyle changes, being able to screen the entire population could prevent ten million cases of Alzheimer’s. What is more, if an effective medication is put on the market (there are more than 20 phase 3 clinical trials for Alzheimer’s drugs currently), then patients could be treated in time, before their cognitive abilities decline.
Can artificial intelligence effectively and reliably assess the quality of body movement and control?
Jenny Älmqvist Nae
The goal of the project is to in a smart, quick and safe way assess movement quality in different environments (e.g., by physiotherapists, occupational therapists, ergonomists, in sports and the workplace) by developing and evaluating a method where artificial intelligence assesses movement quality via a mobile application. The results from the mobile application can guide rehabilitation and preventive measures to improve movement quality, which can reduce the risk of injury / illness, improve performance and the work environment.
New antibody treatment that activates the immune system against cancer
The aim of the project is to develop a new cancer treatment in the form of antibodies to SLAMF6 that can activate the body’s own T cells to attack cancer stem cells, primarily in acute myeloid leukaemia (AML) but potentially also in other cancers. The funds sought would enable the development of therapeutic antibodies by financing patent protection for SLAMF6 as a target for leukaemia stem cells and for the promising antibody to SLAMF6 that we have recently generated.
Development of a new treatment for the blood cancer form acute myeloid leukaemia
Sofia von Palffy
The aim is to eventually develop an antibody-based treatment that attacks the leukemic stem cells in AML. We have discovered a certain receptor shows specifically on the cell surface in one of the most common forms of AML. The receptor does not shown on normal blood stem cells and with the help of antibodies we can target treatment to the diseased cells without damaging the healthy blood cells. As part of the continued development of a new drug, our intention now is to protect our discovery by filing a patent application.
Sorbus Biomedical AB – Evaluation of prototype equipment for extensive cultures of clinically relevant cells
Sorbus Biomedical AB
My goal with this project is to produce and commercialize cutting-edge laboratory equipment intended for more optimal cell cultures. Traditional cell cultivation has major limitations, and I see great potential in being able to satisfy the need for more functional cells. It is therefore my intention, through the development of new technical tools, as well as with solid results that demonstrate the potential of the equipment, to convey a positive change for research, healthcare, and society.
Our main objective is to fill the gap in the existing solutions that help patients in the rehabilitation process of male urinary incontinence. We want to deliver to patients a non-invasive pair of shorts that tracks their exercise and delivers real time evaluation of their performance.